SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/61F0D1294FC80B2B1E0AC3AD00C0E6A265F46CDFFA6C58DC45EB2B64788794AA3B65CCD5B58292588D01B2A4CFFAF37A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/61F0D1294FC80B2B1E0AC3AD00C0E6A265F46CDFFA6C58DC45EB2B64788794AA3B65CCD5B58292588D01B2A4CFFAF37A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/61F0D1294FC80B2B1E0AC3AD00C0E6A265F46CDFFA6C58DC45EB2B64788794AA3B65CCD5B58292588D01B2A4CFFAF37A
http://www.w3.org/2000/01/rdf-schema#comment
"These molecular insights confirm that mutant PDGFRB is indeed the driver mutation in PDGFRB rearranged myeloid neoplasms consistent with the robust treatment responses with imatinib."
xsd:string
http://purl.uniprot.org/uniprot/#_2B3A02E27DC8904D4A2045F548C1A61B452E0B04DE6B04A9B715F2208963947683EE86BCD3F713643E6FB5749117C9D6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/61F0D1294FC80B2B1E0AC3AD00C0E6A265F46CDFFA6C58DC45EB2B64788794AA3B65CCD5B58292588D01B2A4CFFAF37A
http://purl.uniprot.org/uniprot/P09619
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/61F0D1294FC80B2B1E0AC3AD00C0E6A265F46CDFFA6C58DC45EB2B64788794AA3B65CCD5B58292588D01B2A4CFFAF37A
http://purl.uniprot.org/uniprot/#_P09619-mappedCitation-26662677
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/61F0D1294FC80B2B1E0AC3AD00C0E6A265F46CDFFA6C58DC45EB2B64788794AA3B65CCD5B58292588D01B2A4CFFAF37A